...
首页> 外文期刊>Journal of orthopaedic research >Ability of osteoclast formation from peripheral monocytes using anti-fusion regulatory protein-1/CD98/4F2 monoclonal antibodies in patients with osteoporosis.
【24h】

Ability of osteoclast formation from peripheral monocytes using anti-fusion regulatory protein-1/CD98/4F2 monoclonal antibodies in patients with osteoporosis.

机译:在骨质疏松症患者中使用抗融合调节蛋白-1 / CD98 / 4F2单克隆抗体从外周单核细胞形成破骨细胞的能力。

获取原文
获取原文并翻译 | 示例
           

摘要

We investigated the difference in osteoclast formation between patients with osteoporosis and two healthy control groups by inducing it from peripheral blood monocytes with use of anti-fusion regulatory protein- monoclonal antibody. The group of patients with osteoporosis consisted of 35 women and excluded secondary osteoporosis, and the control groups consisted of 12 young healthy volunteers (control I) or 10 individuals age-matched to the patients with osteoporosis (control II). Osteoclast formation declined with age between the two control groups, but this decline was not significant. Fusion rate and the mean number of nuclei in osteoclasts were significantly less in the patients with osteoporosis than in the young or age-matched controls. It was clearly demonstrated that the ability of monocytes to fuse declines significantly in patients with osteoporosis.
机译:我们研究了骨质疏松症患者和两个健康对照组之间破骨细胞形成的差异,方法是使用抗融合调节蛋白单克隆抗体从外周血单核细胞中诱导破骨细胞形成。骨质疏松症患者组由35名女性组成,排除了继发性骨质疏松症,对照组由12名年轻健康志愿者(对照组I)或年龄与骨质疏松症患者年龄匹配的10个人(对照组II)组成。在两个对照组之间,破骨细胞的形成随着年龄的增长而下降,但是这种下降并不明显。骨质疏松症患者的破骨细胞融合率和平均核数目显着低于年轻或年龄相匹配的对照组。清楚地表明,骨质疏松症患者中单核细胞融合的能力显着下降。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号